The Federal Trade Commission (FTC) has initiated a major overhaul of the Express Scripts business model. A landmark settlement will compel Express Scripts, a subsidiary of Cigna Group, to calculate patient costs based on net prices instead of list prices. This agreement mandates the passing of rebates to the end consumer and enhances pricing transparency, thereby accelerating the industry's transition towards a "net-price pharmacy channel."